{"translation": {"zh": "【重要】本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。 —— 病例编号：CASE-1000。", "en": "[Important] A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%). —— Case ID: CASE-1000."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。 —— 病例编号：CASE-1007。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes. —— Case ID: CASE-1007."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "【重要】新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "[Important] The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。 —— 病例编号：CASE-1014。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue. —— Case ID: CASE-1014."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "【重要】实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "[Important] Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。 —— 病例编号：CASE-1021。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma. —— Case ID: CASE-1021."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "【重要】指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "[Important] The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。 —— 病例编号：CASE-1028。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑). —— Case ID: CASE-1028."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。 —— 病例编号：CASE-1035。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%). —— Case ID: CASE-1035."}}
{"translation": {"zh": "【重要】在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "[Important] During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。 —— 病例编号：CASE-1042。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes. —— Case ID: CASE-1042."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "【重要】本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "[Important] A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。 —— 病例编号：CASE-1049。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue. —— Case ID: CASE-1049."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "【重要】新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "[Important] The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。 —— 病例编号：CASE-1056。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma. —— Case ID: CASE-1056."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "【重要】实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。 —— 病例编号：CASE-1063。", "en": "[Important] Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑). —— Case ID: CASE-1063."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。 —— 病例编号：CASE-1070。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%). —— Case ID: CASE-1070."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "【重要】指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "[Important] The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。 —— 病例编号：CASE-1077。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes. —— Case ID: CASE-1077."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "【重要】在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "[Important] During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。 —— 病例编号：CASE-1084。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue. —— Case ID: CASE-1084."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "【重要】本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "[Important] A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。 —— 病例编号：CASE-1091。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma. —— Case ID: CASE-1091."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑)."}}
{"translation": {"zh": "新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
{"translation": {"zh": "本研究共纳入了342例Ⅱ型糖尿病患者（平均年龄：58.7±10.2岁；男性占比=62.4%），采用随机、双盲、安慰剂对照试验（RCT）设计，以评估新型GLP-1受体激动剂对HbA1c水平（基线：8.2%±0.9%）的长期影响。", "en": "A total of 342 patients with type II diabetes mellitus (mean age: 58.7±10.2 years; male proportion=62.4%) were enrolled in this randomized, double-blind, placebo-controlled trial (RCT) to evaluate the long-term impact of a novel GLP-1 receptor agonist on HbA1c levels (baseline: 8.2%±0.9%)."}}
{"translation": {"zh": "在PET/CT成像过程中发现患者纵隔区域存在代谢异常增高灶（SUVmax=12.6），结合临床表现与病理活检结果，最终确诊为霍奇金淋巴瘤（Hodgkin’s lymphoma）。", "en": "During PET/CT imaging, an area of abnormally increased metabolism was observed in the mediastinal region (SUVmax=12.6). Combined with clinical manifestations and pathological biopsy results, the final diagnosis was Hodgkin’s lymphoma."}}
{"translation": {"zh": "指南（《2023年欧洲心脏病学会急性冠脉综合征管理指南》, *Eur Heart J. 2023;44:2543–2632*）明确指出，对于ST段抬高型心肌梗死患者，应在120分钟内完成经皮冠状动脉介入治疗（PCI）。", "en": "The guideline (*2023 ESC Guidelines for the Management of Acute Coronary Syndromes*, Eur Heart J. 2023;44:2543–2632) clearly states that for patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) should be performed within 120 minutes."}}
{"translation": {"zh": "实验室检测结果：血清钾离子浓度=2.8 mmol/L（↓）；血清钠=138 mmol/L（正常）；尿素氮=11.4 mmol/L（↑）；肌酐=150 μmol/L（↑）。 —— 病例编号：CASE-1098。", "en": "Laboratory results: serum potassium concentration=2.8 mmol/L (↓); serum sodium=138 mmol/L (normal); blood urea nitrogen=11.4 mmol/L (↑); creatinine=150 μmol/L (↑). —— Case ID: CASE-1098."}}
{"translation": {"zh": "【重要】新型mRNA疫苗BNT162b2®在III期临床试验（NCT04368728）中显示其保护效力达95%（95% CI: 90.3–97.6），不良事件以注射部位疼痛、短暂发热、乏力为主。", "en": "[Important] The novel mRNA vaccine BNT162b2® demonstrated 95% efficacy (95% CI: 90.3–97.6) in its Phase III clinical trial (NCT04368728), with adverse events primarily consisting of injection site pain, transient fever, and fatigue."}}
